Investment Thesis
Catheter Precision exhibits excellent gross margins (90.3%) and strong revenue growth (95% YoY), indicating product traction, but faces critical financial distress with a liquidity crisis (0.06x current ratio), only $441K cash against $2.8M annual burn, and unsustainable operating losses (-536% margin). The company has approximately 1-2 months of cash runway and presents severe going concern risk absent immediate capital infusion.
Strengths
- Exceptional gross margin (90.3%) indicates strong product economics and market acceptance
- Robust revenue growth (95% YoY) demonstrates market traction from commercialization
- Improving operational performance (EPS improved 89.5% YoY shows trend optimization)
- Conservative leverage (0.32x Debt/Equity) avoids overleveraging during growth phase
- High-barrier medical device sector with regulatory moats
Risks
- Critical liquidity crisis - current ratio of 0.06x indicates severe inability to service short-term obligations
- Severe cash burn ($2.8M annually) with minimal runway - only ~1.5 months of cash remaining
- Massive operating losses (-$2.3M on $432K revenue; -536% operating margin)
- Microscopic revenue base indicates very early commercialization stage with unproven scalability
- Going concern risk requiring immediate dilutive capital raise, debt restructuring, or strategic intervention
- Negative cash flow from operations despite revenue generation indicates unit economics challenges
Key Metrics to Watch
- Cash position and timeline to next funding round or profitability
- Operating cash flow trajectory and path to positive OCF
- Revenue growth sustainability at current 95% YoY rate
- Working capital efficiency and current ratio improvement from 0.06x
- Capital raise announcements, terms, and dilution impact
Financial Metrics
Revenue
432.0K
Net Income
-1.7M
EPS (Diluted)
$-25.98
Free Cash Flow
-2.8M
Total Assets
35.1M
Cash
441.0K
Profitability Ratios
Gross Margin
90.3%
Operating Margin
-536.6%
Net Margin
-389.1%
ROE
-17.6%
ROA
-4.8%
FCF Margin
-648.6%
Balance Sheet & Liquidity
Current Ratio
0.06x
Quick Ratio
0.06x
Debt/Equity
0.32x
Debt/Assets
73.9%
Interest Coverage
-57.95x
Long-term Debt
3.1M
Disclaimer: This analysis is generated by AI based on publicly available SEC EDGAR filings.
It does not include stock price data and should not be considered financial advice.
All fundamental data is sourced from SEC public domain filings.
Always conduct your own research before making investment decisions.
Data Source: SEC EDGAR |
Analysis Date: 2026-05-19T07:23:49.633431 |
Data as of: 2026-03-31 |
Powered by Claude AI